Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | CDC14B | O60729 | 1/20 | 0.31 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23919352 | 0.89 | ADORA3 (0.35) | PIK3CDPIK3CBPRKDCTSHR | |
| SCHEMBL23919408 | 0.88 | ALDH1A1 (0.36) | ALOX5PIK3CDPIK3CBPRKDCTSHR | |
| SCHEMBL22382119 | 0.88 | PGR (0.33) | TSHRKMT2APGR | |
| SCHEMBL23919409 | 0.87 | ALDH1A1 (0.36) | ALOX5PIK3CDPIK3CBPRKDCLMNA | |
| SCHEMBL21687086 | 0.86 | PGR (0.32) | CYP1A1CYP1A2CYP1B1ALOX5PGR | |
| SCHEMBL23919422 | 0.86 | PGR (0.33) | ALOX5MAPTTSHRPGR | |
| SCHEMBL18798572 | 0.85 | ALOX5 (0.38) | ALOX5PIK3CDPIK3CBPRKDCCDC14B | |
| SCHEMBL4079273 | 0.85 | ALOX5 (0.38) | ALOX5PIK3CDPIK3CBPRKDCCDC14B | |
| SCHEMBL29689547 | 0.85 | ALOX5 (0.38) | ALOX5PIK3CDPIK3CBPRKDCCDC14B | |
| SCHEMBL21686945 | 0.85 | PGR (0.35) | MAPTTSHRHTTKMT2APGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | OLA1, TAS2R19, TMEM109 | CYP1A1 1499/4885CYP1A2 1098/4885CYP1B1 2119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.